Aa
REP 9AC combo with immunotherapy an end for Hepatitis B?
Toxicology results from weekly monotherapy exposure to REP 9AC or REP 9AC’ in many cases > 1 year resulted in no observable drug related effects on liver and kidney function or in lipid or hematological function. Major reported symptoms were shown to be related to the development of mineral deficiency likely due to the mineral chelation properties of these compounds and were controlled or prevented with proper mineral supplementation during treatment.
All patients have achieved HBV antibody levels seen in healthy patients after vaccination with a total of 12 weeks of combination treatment and many patients have achieved antibody titers > 1000 mIU / ml. In 8 out of 9 patients who have achieved this therapeutic vaccine-like response, they continue to control their viral infection 12 – 24 weeks after all treatment is stopped.
All patients have achieved HBV antibody levels seen in healthy patients after vaccination with a total of 12 weeks of combination treatment and many patients have achieved antibody titers > 1000 mIU / ml. In 8 out of 9 patients who have achieved this therapeutic vaccine-like response, they continue to control their viral infection 12 – 24 weeks after all treatment is stopped.
http://www.torrinomedica.it/farmaci/schedetecniche/Zadaxin.asp#axzz2Y6uzIuhQ
i m not expert on its use, anyway these italian health pages describe its use as vaccine booster and doses according to kg of weight, if you use chrome translation to english should not be bad
http://www.rxlist.com/zadaxin-drug/indications-dosage.htm
Chronic Hepatitis B
The recommend-ed dose of ZADAXIN (thymalfasin) for chronic hepatitis B when used as a monotherapy or in combination with interferon (at the labeled dose and schedule for interferon) is 1.6 mg (900 µg/m2) administered subcutaneously twice a week for 6 to 12 months. Patients weighing less than 40 kg should receive a ZADAXIN (thymalfasin) dose of 40 µg/kg.
i m not expert on its use, anyway these italian health pages describe its use as vaccine booster and doses according to kg of weight, if you use chrome translation to english should not be bad
http://www.rxlist.com/zadaxin-drug/indications-dosage.htm
Chronic Hepatitis B
The recommend-ed dose of ZADAXIN (thymalfasin) for chronic hepatitis B when used as a monotherapy or in combination with interferon (at the labeled dose and schedule for interferon) is 1.6 mg (900 µg/m2) administered subcutaneously twice a week for 6 to 12 months. Patients weighing less than 40 kg should receive a ZADAXIN (thymalfasin) dose of 40 µg/kg.
The whole abstract is posted here on forums as study summary so this is all legit. I think djxpress posted it.
i m not saying that its bogus data. i am only suggesting why don't they publish in good journals to get scince community attention and publish it in media to get public, government, investors attention.
So you are saying they pose bogus data? I tend to believe their results.
Believe me HBV is curable with what is available today that they wont release today.
Believe me HBV is curable with what is available today that they wont release today.
Have an Answer?
You are reading content posted in the Hepatitis B Community
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.
PrEP is used by people with high risk to prevent HIV infection.
